TY - JOUR
T1 - Characterization of the airway response to inhaled leukotriene D4 in normal subjects
AU - Kern, R.
AU - Smith, L. J.
AU - Patterson, R.
AU - Krell, R. D.
AU - Bernstein, P. R.
PY - 1986
Y1 - 1986
N2 - To better understand the role of leukotriene D4 (LTD4) in the pathogenesis of airway hyperreactivity, we administered aerosolized LTD4, on multiple occasions to 6 normal subjects and measured specific airway conductance (SGaw) by body plethysmography and the flow rate at 30% of vital capacity from partial forced expiratory maneuvers (V30P). Dose-response curves generated from standard bronchoprovocation tests revealed that LTD4, was 280 to 590 times more potent as a bronchoconstrictor than was methacholine. The airways response to single bronchoconstricting doses of LTD4, administered on separate days was reproducible for SGaw (r = 0.86, p < 0.05) and V30P (r = 0.95, p < 0.005). The response to 3 consecutive single-dose LTD4 challenges performed on the same day, allowing SGaw and V30P to return to > 90% of the control value between challenges, demonstrated tachyphylaxis: the response to the third dose was significantly less than the response to the first dose for SGaw (p < 0.001) and for V30P (p < 0.01). A single bronchoconstricting dose of LTD4, given before a standard methacholine dose-response challenge, lowered the concentration of methacholine needed to decrease V30P 30% (p < 0.05) and SGaw 35% (p = 0.09). A single bronchoconstricting dose of methacholine preceding a standard methacholine challenge did not have this effect. LTD4, and methacholine demonstrates a cumulative dose-effect when progressively higher concentrations were inhaled. In summary, the airway response to LTD4 is reproducible, exhibits tachyphylaxis, and a cumulative dose-effect occurs. As well, LTD4 increases the responsiveness of normal airways to methacholine.
AB - To better understand the role of leukotriene D4 (LTD4) in the pathogenesis of airway hyperreactivity, we administered aerosolized LTD4, on multiple occasions to 6 normal subjects and measured specific airway conductance (SGaw) by body plethysmography and the flow rate at 30% of vital capacity from partial forced expiratory maneuvers (V30P). Dose-response curves generated from standard bronchoprovocation tests revealed that LTD4, was 280 to 590 times more potent as a bronchoconstrictor than was methacholine. The airways response to single bronchoconstricting doses of LTD4, administered on separate days was reproducible for SGaw (r = 0.86, p < 0.05) and V30P (r = 0.95, p < 0.005). The response to 3 consecutive single-dose LTD4 challenges performed on the same day, allowing SGaw and V30P to return to > 90% of the control value between challenges, demonstrated tachyphylaxis: the response to the third dose was significantly less than the response to the first dose for SGaw (p < 0.001) and for V30P (p < 0.01). A single bronchoconstricting dose of LTD4, given before a standard methacholine dose-response challenge, lowered the concentration of methacholine needed to decrease V30P 30% (p < 0.05) and SGaw 35% (p = 0.09). A single bronchoconstricting dose of methacholine preceding a standard methacholine challenge did not have this effect. LTD4, and methacholine demonstrates a cumulative dose-effect when progressively higher concentrations were inhaled. In summary, the airway response to LTD4 is reproducible, exhibits tachyphylaxis, and a cumulative dose-effect occurs. As well, LTD4 increases the responsiveness of normal airways to methacholine.
UR - http://www.scopus.com/inward/record.url?scp=0022614879&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022614879&partnerID=8YFLogxK
M3 - Article
C2 - 3521417
AN - SCOPUS:0022614879
SN - 0003-0805
VL - 133
SP - 1127
EP - 1132
JO - American Review of Respiratory Disease
JF - American Review of Respiratory Disease
IS - 6
ER -